Neeraj Mahajan in Parma, Ohio

Home Ohio Parma

Neeraj Mahajan has Hematology as his primary medical specialty. Their primary office is: 6525 Powers Blvd in Parma, Ohio. There is an additional office location, for a total of two, for Neeraj Mahajan that can be viewed further down.

They're a part of the: University Primary Care Practices Inc medical group which has around 959 members. You can call their office at 440-743-4748 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 1994 (around 30 years of experience). They are listed as doing telehealth appointments.

Neeraj Mahajan Office Phone and Directions

Neeraj Mahajan
University Primary Care Practices Inc
6525 Powers Blvd
Parma, Ohio 44129
440-743-4748

Patient Ratings
Please rate your experience with Neeraj Mahajan below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 440-743-4748

Enter a starting address:

Healthcare Info for Neeraj Mahajan

Medical School: Sorry, his university is not listed
Graduation Year: 1994
The Primary Medical Specialty for Neeraj Mahajan is listed as: Hematology
Approximate Years of Experience: 30
PAC (PECOS ID)#: 0042384042
NPI #: 1194718692
NPI Created On: 08/30/2005
NPI Last Updated Listed as: 01/14/2021
Primary Taxonomy Code: 207RH0003X
License Number:
23780
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Summa Insurance Company, Inc.
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

New patient office or other outpatient visit, typically 60 minutes
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Established patient office or other outpatient, visit typically 40 minutes
Initial hospital inpatient care, typically 50 minutes per day
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 15 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day
Physician telephone patient service, 21-30 minutes of medical discussion
Physician telephone patient service, 21-30 minutes of medical discussion

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $100

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787976061

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781012543

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781012545

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818609393

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: CYRAMZA

Open Associated Drug #1: 0002-7669-01

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: VERZENIO

Associated Drug #2: 0002-6216-54

Drug or Biological #3:: Drug

Product Category #3: Oncology

Name of Drug: RETEVMO

Name Of Drug #3: 0002-2980-60

Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818614379

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: CYRAMZA

Open Associated Drug #1: 0002-7669-01

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: VERZENIO

Associated Drug #2: 0002-6216-54

Drug or Biological #3:: Drug

Product Category #3: Oncology

Name of Drug: RETEVMO

Name Of Drug #3: 0002-2980-60

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818657795

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: CYRAMZA

Open Associated Drug #1: 0002-7669-01

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: RETEVMO

Associated Drug #2: 0002-2980-60

Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818660179

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: CYRAMZA

Open Associated Drug #1: 0002-7669-01

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: RETEVMO

Associated Drug #2: 0002-2980-60

Payments Total: $2,750

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 803041401

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: ONCOLOGY

Name of Drug #1: BLENREP

Open Associated Drug #1: 0173-0896-01

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 803177019

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: ONCOLOGY

Name of Drug #1: BLENREP

Open Associated Drug #1: 0173-0896-01

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832138409

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: PADCEV

Open Associated Drug #1: 51144-030-01

Additional Office Locations

1. University Primary Care Practices Inc
5133 Ridge Rd
Wadsworth, OH 44281
Suite 1
Group Members: 959

Phone: 440-743-4748

Enter a starting address:

Providers in University Primary Care Practices Inc

1.Mustafa Abas

13207 Ravenna Rd
Chardon Oh 44024-7032
University Primary Care Practices Inc
Pulmonary Disease

2.Hassan Abbass Md

34055 Solon Rd
Solon Oh 44139-2662
University Primary Care Practices Inc
Otolaryngology

3.Rami Abbass

8185 Washington St
Chagrin Falls Oh 44023-4574
University Primary Care Practices Inc
Gastroenterology

4.Rami Abbass

9000 Mentor Ave
Mentor Oh 44060-4497
University Primary Care Practices Inc
Gastroenterology

5.Ademola Abiose Md

630 E River St
Elyria Oh 44035-5902
University Primary Care Practices Inc
Cardiovascular Disease (cardiology)

6.Ademola Abiose Md

125 E Broad St
Elyria Oh 44035-6447
University Primary Care Practices Inc
Cardiovascular Disease (cardiology)

View all 959 members of University Primary Care Practices Inc medical group